The structures, stabilities, and isomerization patterns of C5H9+ ions arising from the gas-phase protonation of spiropentane have been investigated by nuclear-decay, radiolytic, and FT-ICR techniques combined with ab initio calculations. The experimental and theoretical results are consistent with the initial formation of a corner-protonated spiropentane intermediate 17, whose lifetime in the gas phase exceeds 7 X 10(-9) s. This local C5H9+ minimum is separated from the ca. 30 kcal mol-1 more stable cyclopentyl cation as well as from dimethylallyl open-chain isomers by significant energy barriers. Persistency of 17 in the gas phase does not find any correspondence in solution. Solvation and ion-pairing effects may explain the failure to detect C5H9+ structures retaining the spirobicyclic framework of spiropentane in the condensed phase.
Gas-phase Protonation of Spiropentane - A Novel Entry Into the C5h9+ Potential-energy Surface / P., Cecchi; A., Pizzabiocca; G., Renzi; F., Grandinetti; C., Sparapani; P., Buzek; P. V., Schleyer; Speranza, Maurizio. - In: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. - ISSN 0002-7863. - STAMPA. - 115:(1993), pp. 10338-10347. [10.1021/ja00075a058]
Gas-phase Protonation of Spiropentane - A Novel Entry Into the C5h9+ Potential-energy Surface
SPERANZA, Maurizio
1993
Abstract
The structures, stabilities, and isomerization patterns of C5H9+ ions arising from the gas-phase protonation of spiropentane have been investigated by nuclear-decay, radiolytic, and FT-ICR techniques combined with ab initio calculations. The experimental and theoretical results are consistent with the initial formation of a corner-protonated spiropentane intermediate 17, whose lifetime in the gas phase exceeds 7 X 10(-9) s. This local C5H9+ minimum is separated from the ca. 30 kcal mol-1 more stable cyclopentyl cation as well as from dimethylallyl open-chain isomers by significant energy barriers. Persistency of 17 in the gas phase does not find any correspondence in solution. Solvation and ion-pairing effects may explain the failure to detect C5H9+ structures retaining the spirobicyclic framework of spiropentane in the condensed phase.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.